Shakira is No. 1 on Billboard’s Top Tours chart for March, back on top after ruling the February edition. She led last month’s list with $32.9 million but doubles her earnings on the newest update. According to figures reported to Billboard Boxscore, Las Mujeres Ya No Lloran World Tour earned $70.6 million from 11 reported shows. That’s more than any act has grossed in any March since the charts launched in 2019.
Monthly grosses typically balloon during the summer, when summer weather allows for stadium shows in the U.S. and Europe. With most acts confined to indoor arenas in the fall, winter, and spring, Shakira’s Latin roots fueled a massive stadium run in Central and South America and Mexico. She surpasses Bad Bunny’s March 2024, Coldplay in 2023, Bad Bunny again in 2022, the Backstreet Boys in 2020, and P!nk in 2019. (There was no ranking in March 2021 due to COVID-19).
Mexico was the setting of Shakira’s March shows, hitting Monterrey and Guadalajara before climaxing in Mexico City. There, the Colombian superstar played seven shows at Estadio GNP Seguros from March 19-30, bringing in $46.6 million from 396,000 tickets sold. Those shows are No. 1 on Top Boxscore, more than tripling the gross of No. 2.
Shakira’s seven Mexico City shows set a venue record, eclipsing RBD’s six nights (2023), Daddy Yankee’s five (2022), and Taylor Swift’s four (2023). But demand was so outrageous that she announced four more dates at the same stadium in August, extending to 11 shows.
The Estadio GNP Seguros shows alone would have secured Shakira the No. 1 spot on Top Tours, but her schedule also included two shows apiece in Monterrey ($12.5 million; 88.2K tickets) and Guadalajara ($11.5 million; 70.3K).
Including the tour’s first shows in February and further dates in April, Las Mujeres Ya No Lloran World Tour has earned a reported $111 million and sold 910,000 tickets in Latin America. Shakira re-ups in Charlotte, N.C. on May 13 to begin a 23-show run in the U.S. and Canada. Then, she’ll be back in Mexico, Dominican Republic, and Peru for 18 more dates through November.
Just as Shakira was No. 1 in February and one-upped herself in March, Tyler, the Creator scores a second consecutive month at No. 2 with increased totals. This month, Tyler earned $36.2 million and sold 221,000 tickets, up 25% and 17%, respectively, from last month. It’s the first time that two acts repeated on top in consecutive months in three years, when Bad Bunny and Elton John went 1-2, respectively, in February and March 2022.
Three years after crowning Boxscore charts with his six band mates, BTS’ J-Hope is No. 3 on Top Tours with his first solo shows. Across 10 dates in March, he brought in $26.6 million and sold 149,000 tickets. After three home-town shows in Seoul, he toured North America. Like Shakira, his March peak was in Mexico City, with a $6.1 million double-header at Palacio de los Deportes on March 22-23.
TOMORROW X TOGETHER and NCT 127 represent K-pop elsewhere, with $10.6 million and $7 million, respectively.
Dead & Company follows at No. 4, with the Eagles trailing at No. 7. Both classic rock acts played shows at Las Vegas’ Sphere. As has become common in the last year and a half, the Sin City arena is No. 1 on the Top Venues (15,001+ capacity) chart, combining both bands’ dates – plus two from Anyma – for $45.4 million and 195,000 tickets.
Country music is rooted in the U.S. and has historically struggled to export internationally. So it’s a welcome surprise that this month’s roster of charting country tours include Jelly Roll in Canada, Chris Stapleton in Australia and New Zealand, and C2C Country To Country across the United Kingdom.
Shakira and J-Hope provided Mexican promoter OCESA with some of its biggest wins during March. But they crowd the top 10 of Top Boxscores further with two festivals. Mexico City’s Vive Latino Festival grossed $14.2 million and sold 146,000 tickets in the middle of the month, and Bogota’s Festival Estereo Picnic earned $10.1 million in March’s final days. Altogether, OCESA grossed $140 million and sold 1.3 million tickets.
